AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,013,000 | +574.5% | 2,508,261 | +1294.6% | 0.28% | +787.5% |
| Q3 2018 | $595,000 | +46.6% | 179,853 | +0.2% | 0.03% | +33.3% |
| Q2 2018 | $406,000 | -9.4% | 179,512 | +16.3% | 0.02% | -25.0% |
| Q1 2018 | $448,000 | +17.3% | 154,378 | +12.8% | 0.03% | +6.7% |
| Q4 2017 | $382,000 | -51.9% | 136,908 | -79.1% | 0.03% | +20.0% |
| Q3 2015 | $794,000 | -33.3% | 656,551 | -4.1% | 0.02% | -26.5% |
| Q2 2015 | $1,191,000 | +19.9% | 684,651 | 0.0% | 0.03% | +21.4% |
| Q1 2015 | $993,000 | +74.8% | 684,651 | +1.2% | 0.03% | +64.7% |
| Q4 2014 | $568,000 | -24.4% | 676,451 | 0.0% | 0.02% | -26.1% |
| Q3 2014 | $751,000 | -39.3% | 676,451 | 0.0% | 0.02% | -36.1% |
| Q2 2014 | $1,238,000 | +22.5% | 676,451 | 0.0% | 0.04% | +33.3% |
| Q1 2014 | $1,011,000 | +16.3% | 676,451 | +42.5% | 0.03% | +22.7% |
| Q4 2013 | $869,000 | -11.1% | 474,651 | 0.0% | 0.02% | -15.4% |
| Q3 2013 | $978,000 | -17.6% | 474,651 | 0.0% | 0.03% | -23.5% |
| Q2 2013 | $1,187,000 | – | 474,651 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
| New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
| RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
| NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
| Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
| 683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
| Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
| EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
| Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |